Job Description Summary
The Development QA Manager is a key player in the Country Development Quality group in Spain who are highly valued by major stakeholders, the cluster, and the entire European CDQ community.
Job Description
Location: Barcelona, Spain
Working model: Hybrid working model (which requires 12 days per month in the office)
Note: Novartis is not able to offer relocation support for this role. Please only apply if this location is accessible for you.
This is a dynamic role and no two days are the same! You'll be constantly interacting with different stakeholders, tackling various cases related to diverse procedures and regulations. Your QA expertise will make you a go-to subject matter expert for colleagues and processes.
Joining us would be an opportunity to join a success story and become a part of it!
Key Responsibilities:
- Local Quality System: Oversee implementation, maintenance, and monitoring of the local Quality System and written procedures to ensure GCP and Pharmacovigilance related processes and tasks are compliant with Novartis global requirements and applicable regulations and guidelines.
- Quality Plan and Continuous Improvement: Support and monitor implementation of the local Quality Plan (QP) deliverables related to GCP and PV areas, ensuring alignment with the applicable global QP chapters wherever possible.
- Training systems: Ensure adequate training systems are in place in assigned country(ies) for GCP, GPvP and other relevant Development activities in compliance with Novartis global and local requirements. Assure that relevant business areas are maintaining inspection-ready documentation to support reviews of training compliance.
- Quality Issue Management: Drive Clinical/PV QA investigation activities at the country level as appropriate and ensure implementation of robust CAPA plans where applicable.
- Risk Identification and Management: Monitor local Quality System, processes and Key Quality Indicators (KQIs) to proactively identify potential quality risk. Collaborate with business partners to ensure that risks are reviewed for root cause, impact, and recurrence and assure that relevant line function owners put in place mitigation plans to address.
- Inspection Management and Support: Provide leadership and/or support as needed for GCP and GPvP HA inspections of activities in assigned country(ies). Assure support prior to, during and post inspection for the country organization, investigational sites and/or external service providers, as applicable, in collaboration with the assigned inspection lead.
- Audit Management: Partner with local and global Development teams, PS, NCQ and other internal stakeholders in the execution, where QA processes are subject to the audit, and follow-up of audits on clinical development and PV activities.
- CAPA management: Act as local approver for the documentation and management of local CAPAs to support appropriate review and closure of each corrective and preventive action.
Role Requirements:
- Degree in Life Sciences or Health Science.
- 5+ years of pharmaceutical industry experience with significant experience in pharma drug development in a relevant field such as quality assurance, regulatory affairs, pharmacovigilance or a directly related area.
- At least 3 years of experience in clinical development.
- Experience with project management and leading projects
- Fluent English (both spoken and written)
Additional beneficial skills:
- Fluent Spanish would be an advantage
Skills Desired
Agility, Analytical Development, Auditing, Audit Management, Business Partnering, Change Control, Continued Learning, Health Authorities, Influencing Skills, Knowledge Of Capa, Qa (Quality Assurance), Quality Management, Risk Management, Root Cause Analysis (RCA), Self-Awareness, Six Sigma, Sop (Standard Operating Procedure), Technological Expertise
Top Skills
What We Do
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.